Survival in Systemic Sclerosis With Pulmonary Arterial Hypertension Has Not Improved in the Modern Era
- 1 October 2013
- journal article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 144 (4), 1282-1290
- https://doi.org/10.1378/chest.12-0653
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trialsThe Journal of Heart and Lung Transplantation, 2011
- Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals Of The Rheumatic Diseases, 2010
- The three‐year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in FranceArthritis & Rheumatism, 2009
- Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung diseaseArthritis & Rheumatism, 2009
- Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie studyRheumatology, 2008
- Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertensionEuropean Respiratory Journal, 2007
- Clinical differences between idiopathic and scleroderma‐related pulmonary hypertensionArthritis & Rheumatism, 2006
- Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter studyArthritis & Rheumatism, 2005
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals Of The Rheumatic Diseases, 2003